Chris Rallis - 15 Aug 2024 Form 4 Insider Report for FENNEC PHARMACEUTICALS INC. (FENC)

Role
Director
Signature
/s/ Chris Rallis
Issuer symbol
FENC
Transactions as of
15 Aug 2024
Transactions value $
$111,600
Form type
4
Date filed
19 Aug 2024, 19:00
Previous filing
08 Jul 2024
Next filing
10 Oct 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FENC Stock Option Award $112K +20K +11.32% $5.58 197K 15 Aug 2024 Common shares 20K $5.58 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On August 15, 2024, Chris Rallis was granted a non-qualified stock option to purchase 20,000 shares of the issuer's common shares pursuant to the issuer's Equity Incentive Plan.
F2 The option is 100% vested of date of grant.